AMG837GPR40 agonist,orally bioavailable CAS# 865231-46-5 |
- Nutlin-3a chiral
Catalog No.:BCC1812
CAS No.:675576-98-4
- p53 and MDM2 proteins-interaction-inhibitor chiral
Catalog No.:BCC1830
CAS No.:939981-37-0
- p53 and MDM2 proteins-interaction-inhibitor racemic
Catalog No.:BCC1831
CAS No.:939983-14-9
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 865231-46-5 | SDF | Download SDF |
PubChem ID | 46854655 | Appearance | Powder |
Formula | C26H21F3O3 | M.Wt | 438.44 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3S)-3-[4-[[3-[4-(trifluoromethyl)phenyl]phenyl]methoxy]phenyl]hex-4-ynoic acid | ||
SMILES | CC#CC(CC(=O)O)C1=CC=C(C=C1)OCC2=CC=CC(=C2)C3=CC=C(C=C3)C(F)(F)F | ||
Standard InChIKey | ZOPNBMMVVZRSGH-NRFANRHFSA-N | ||
Standard InChI | InChI=1S/C26H21F3O3/c1-2-4-21(16-25(30)31)20-9-13-24(14-10-20)32-17-18-5-3-6-22(15-18)19-7-11-23(12-8-19)26(27,28)29/h3,5-15,21H,16-17H2,1H3,(H,30,31)/t21-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | AMG 837 is a potent GPR40 agonist(EC50=13 nM) with a superior pharmacokinetic profile and robust glucose-dependent stimulation of insulin secretion in rodents.
IC50 value: 13 nM (EC50) [1]
Target: GPR40 agonist
AMG 837 displayed the expected two-fold increase in potency on GPR4 (EC50 = 13 [±7] nM) compared to the racemic compound and its activity crossed over to the rat and mouse forms of GPR40 (EC50 = 23 and 13 nM, respectively). AMG 837 was found to be a partial agonist on GPR40 with maximal activity 85% of that shown by DHA under our standard assay conditions. AMG 837 is a highly potent stimulator of insulin secretion in MIN6 cells with an EC50 comparable to that seen in the aequorin Ca2+-flux assay. showed
no significant activity in cell-based assays against PPARα, δ, and γ. An external panel of 64 receptors also revealed no significant activity with the exception of weak inhibition (IC50 = 3 uM) on the a2-adrenergic receptor. Overall, AMG 837 was both highly potent
and selective in vitro. References: |
AMG837 Dilution Calculator
AMG837 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.2808 mL | 11.4041 mL | 22.8081 mL | 45.6163 mL | 57.0203 mL |
5 mM | 0.4562 mL | 2.2808 mL | 4.5616 mL | 9.1233 mL | 11.4041 mL |
10 mM | 0.2281 mL | 1.1404 mL | 2.2808 mL | 4.5616 mL | 5.702 mL |
50 mM | 0.0456 mL | 0.2281 mL | 0.4562 mL | 0.9123 mL | 1.1404 mL |
100 mM | 0.0228 mL | 0.114 mL | 0.2281 mL | 0.4562 mL | 0.5702 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
AMG 837 is a potent and orally bioavailable GPR40 agonist (EC50=14nM). [1]
GPR40 is a G protein-coupled receptor that is activated by free fatty acid. It is located on the cell surface of pancreatic beta-cells, gastrointestinal enteroendocrine cells and immune cells etc. GPR40 is reported to be related the stimulation effects of fatty acids on insulin and incretin secretion. [2]
AMG 837 treatment on GPR40 containing cell membrane increases [35S]-GTPγ binding (EC=1.5±0.1 nM). AMG 837 also stimulates Ca2+ influx (EC50 = 13.5±0.8 nM) in CHO cells transfected with GPR40 and aequorin. [2]
The insulin secretion is stimulated and the postprandial glucose level is lowered in 8-week old Sprague-Dawley rats orally treated with AMG 837. In Zucker fatty rats treated with AMG 837 daily for 21-days shows decreased glucose excursions and elevated glucose stimulated insulin secretion in glucose tolerance tests. [2]
References:
1. Houze JB, Zhu L, Sun Y et al. AMG 837: a potent, orally bioavailable GPR40 agonist. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1267-70.
2. Lin DC, Zhang J, Zhuang R et al. AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents. PLoS One. 2011;6(11):e27270.
- Gelsempervine A
Catalog No.:BCN3929
CAS No.:865187-17-3
- Vinblastine
Catalog No.:BCN2376
CAS No.:865-21-4
- BMS-663068 Tris
Catalog No.:BCC1429
CAS No.:864953-39-9
- BMS-663068
Catalog No.:BCC1428
CAS No.:864953-29-7
- Leojaponin
Catalog No.:BCN7381
CAS No.:864817-63-0
- Resminostat (RAS2410)
Catalog No.:BCC2165
CAS No.:864814-88-0
- Gnetucleistol C
Catalog No.:BCN3395
CAS No.:864763-61-1
- Gnetucleistol B
Catalog No.:BCN3585
CAS No.:864763-60-0
- TC-MCH 7c
Catalog No.:BCC6149
CAS No.:864756-35-4
- SB 699551
Catalog No.:BCC7594
CAS No.:864741-95-7
- Sequosempervirin D
Catalog No.:BCN4562
CAS No.:864719-19-7
- Sequosempervirin B
Catalog No.:BCN4777
CAS No.:864719-17-5
- 4,5-dihydroxy-3,8-dimethylnaphthalene-1,2-dione
Catalog No.:BCN8422
CAS No.:86533-36-0
- FR 180204
Catalog No.:BCC3669
CAS No.:865362-74-9
- N-Methylcalycinine
Catalog No.:BCN4412
CAS No.:86537-66-8
- Benazepril HCl
Catalog No.:BCC5019
CAS No.:86541-74-4
- Benazepril
Catalog No.:BCC4286
CAS No.:86541-75-5
- apigenin 7-O-(6〃-O-malonyl)-β-D-glucoside
Catalog No.:BCN8399
CAS No.:86546-87-4
- Narlaprevir
Catalog No.:BCC1785
CAS No.:865466-24-6
- Bisisorhapontigenin A
Catalog No.:BCN3501
CAS No.:865474-98-2
- 5-R-Rivaroxaban
Catalog No.:BCC1313
CAS No.:865479-71-6
- Junipediol A
Catalog No.:BCN6912
CAS No.:86548-91-6
- Ganoderic acid SZ
Catalog No.:BCN4413
CAS No.:865543-37-9
- TC-E 5001
Catalog No.:BCC6355
CAS No.:865565-29-3